SG10201403497QA - Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor - Google Patents

Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor

Info

Publication number
SG10201403497QA
SG10201403497QA SG10201403497QA SG10201403497QA SG10201403497QA SG 10201403497Q A SG10201403497Q A SG 10201403497QA SG 10201403497Q A SG10201403497Q A SG 10201403497QA SG 10201403497Q A SG10201403497Q A SG 10201403497QA SG 10201403497Q A SG10201403497Q A SG 10201403497QA
Authority
SG
Singapore
Prior art keywords
manufacturing processes
medical treatments
based nanocrystals
processes therefor
novel gold
Prior art date
Application number
SG10201403497QA
Other languages
English (en)
Inventor
Mark Mortenson
D Kyle Pierce
David Bryce
Adam Dorfman
Reed Wilcox
Anthony Lockett
Mikhail Merzliakov
Original Assignee
Gr Intellectual Reserve Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Intellectual Reserve Llc filed Critical Gr Intellectual Reserve Llc
Publication of SG10201403497QA publication Critical patent/SG10201403497QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/0545—Dispersions or suspensions of nanosized particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/0553—Complex form nanoparticles, e.g. prism, pyramid, octahedron
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F9/00—Making metallic powder or suspensions thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B1/00—Single-crystal growth directly from the solid state
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/02—Elements
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/60—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/12—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by electrolysis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Electrochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Composite Materials (AREA)
SG10201403497QA 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor SG10201403497QA (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22394409P 2009-07-08 2009-07-08
US22615309P 2009-07-16 2009-07-16
US22825009P 2009-07-24 2009-07-24
US23557409P 2009-08-20 2009-08-20
US24980409P 2009-10-08 2009-10-08
US26364809P 2009-11-23 2009-11-23
US29469010P 2010-01-13 2010-01-13

Publications (1)

Publication Number Publication Date
SG10201403497QA true SG10201403497QA (en) 2014-10-30

Family

ID=43429549

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10202108051XA SG10202108051XA (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
SG10201908339R SG10201908339RA (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
SG2012001319A SG177565A1 (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
SG10201403497QA SG10201403497QA (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SG10202108051XA SG10202108051XA (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
SG10201908339R SG10201908339RA (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
SG2012001319A SG177565A1 (en) 2009-07-08 2010-07-08 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor

Country Status (16)

Country Link
US (5) US9603870B2 (enExample)
EP (1) EP2451284B8 (enExample)
JP (4) JP6059015B2 (enExample)
KR (3) KR101931381B1 (enExample)
CN (1) CN102548417B (enExample)
AU (1) AU2010271298B2 (enExample)
BR (1) BR112012000311B1 (enExample)
CA (1) CA2767428C (enExample)
DK (1) DK2451284T3 (enExample)
ES (1) ES2623504T3 (enExample)
IL (1) IL217408A (enExample)
MX (2) MX350309B (enExample)
PH (1) PH12017501884A1 (enExample)
RU (1) RU2568850C2 (enExample)
SG (4) SG10202108051XA (enExample)
WO (1) WO2011006007A1 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2178796T1 (sl) * 2007-07-11 2021-04-30 Clene Nanomedicine, Inc. Kontinuiran postopek za obdelavo tekočin in proizvodnjo določenih sestavin
US9387452B2 (en) 2009-01-14 2016-07-12 Gr Intellectual Reserve, Llc. Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
DK2387478T3 (en) 2009-01-15 2018-10-29 Clene Nanomedicine Inc CONTINUOUS PROCESS AND APPARATUS FOR THE CREATION OF GOLD-BASED NANOPARTICLES
EP2451284B8 (en) * 2009-07-08 2017-05-24 Clene Nanomedicine, Inc. Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
WO2011158176A2 (en) * 2010-06-17 2011-12-22 University Of Kwazulu-Natal Gold complexes
US20130323166A1 (en) * 2010-09-10 2013-12-05 William Beaumont Hospital Radiation Therapy for Treating Alzheimer's Disease
PH12013501954A1 (en) * 2011-03-30 2013-11-25 Clene Nanomedicine Inc Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
AU2014262673B2 (en) * 2013-05-08 2019-12-05 Clene Nanomedicine, Inc. Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination
GB2529185B (en) 2014-08-12 2021-03-03 Kathrein Se Method and system for relaying telecommunications signals wtih efficient joint capacity
EP4574044A3 (en) 2014-10-30 2025-08-27 Kardium Inc. Systems and methods for ablating tissue
KR102328995B1 (ko) * 2014-11-26 2021-11-23 나노리소스 주식회사 폭발형 나노다이아몬드의 분리 방법
CN104867267B (zh) * 2015-03-15 2017-10-27 李洪 节能减灾装置
CN104759753B (zh) * 2015-03-30 2016-08-31 江苏大学 多系统自动化协调工作提高激光诱导空化强化的方法
US11179490B2 (en) * 2015-05-07 2021-11-23 The Regents Of The University Of Michigan Process for electro-hydrodynamically enhanced destruction of chemical air contaminants and airborne inactivation of biological agents
JP6590309B2 (ja) * 2015-07-31 2019-10-16 学校法人関東学院 導電層付プラスチック基板及びその製造方法
US11311940B2 (en) 2016-05-25 2022-04-26 University Of Florida Research Foundation, Inc. Light-driven synthesis of plasmonic nanoparticles and nanomaterials
US12311448B2 (en) 2016-05-25 2025-05-27 University Of Florida Research Foundation, Inc. Light-driven synthesis of plasmonic nanoparticles and nanomaterials
CN107684560B (zh) * 2016-08-05 2021-05-11 深圳深见医药科技有限公司 含金团簇的物质在制备预防和治疗阿兹海默病药物中的应用
US10300551B2 (en) * 2016-11-14 2019-05-28 Matthew Fagan Metal analyzing plasma CNC cutting machine and associated methods
US10195683B2 (en) * 2016-11-14 2019-02-05 Matthew Fagan Metal analyzing plasma CNC cutting machine and associated methods
US10029019B1 (en) 2017-01-20 2018-07-24 Xueyun Gao Method for mitigating osteoporosis using metallic gold cluster molecules
CN108569483A (zh) * 2017-03-13 2018-09-25 富泰华工业（深圳）有限公司 智能取液系统
US11103878B2 (en) 2017-04-03 2021-08-31 Yale University Electrochemical separation and recovery of metals
CN107217279B (zh) * 2017-05-31 2018-10-02 东北大学 一种电解法制备金属纳米颗粒的方法
CN107290422B (zh) * 2017-07-20 2019-04-19 浙江大学 一种基于电化学增强反射光谱信号的生化检测系统及方法
TWI651095B (zh) * 2017-10-18 2019-02-21 晶碩光學股份有限公司 具有抗敏舒緩效果的眼用產品
ES2998117T3 (en) 2017-12-19 2025-02-19 Nanobiotix Nanoparticles for use in enhancing brain performances or in treating stress
KR102729931B1 (ko) 2017-12-19 2024-11-13 나노비오?笭? 신경 장애의 치료에서 사용하기 위한 나노입자
EP3696534A1 (en) 2019-02-14 2020-08-19 SmartDyeLivery GmbH Method for determining physicochemical properties of nanoscale systems (nss)
CN110905454B (zh) * 2019-11-29 2022-01-04 南通仁隆科研仪器有限公司 一种水合物储层井间电学动态监控模拟实验装置
HUE069670T2 (hu) * 2019-12-27 2025-04-28 Wuhan Vast Conduct Science Found Co Ltd Készítmény és módszer a sclerosis multiplex kezelésére
RU2725197C1 (ru) * 2020-02-12 2020-06-30 федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации Метод оценки висцеральной гиперчувствительности
KR102408166B1 (ko) 2020-04-02 2022-06-10 아주대학교산학협력단 세포 배양이 가능한 세포 유래물 분석용 센서칩, 및 이를 이용한 세포 활성도 정량 분석 방법
CN112571790A (zh) * 2020-11-04 2021-03-30 即时智造科技(上海)有限公司 一种sls3d打印自动冷却装置
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
EP4347928A4 (en) 2021-06-01 2025-02-12 NTH Cycle, Inc. Electrochemical metal deposition system and method
CN115351289B (zh) * 2022-09-01 2023-12-29 杭州师范大学 一种利用三元表面活性剂制备微型金纳米棒的方法及其产品
CN116125487A (zh) * 2023-02-01 2023-05-16 厦门大学 一种涡旋光束综合多普勒频移测量的系统及方法
KR102800996B1 (ko) * 2024-01-26 2025-04-29 연세대학교 산학협력단 나노 물질의 전기화학적 합성에서 국부 가열 유도 단결정상 제어

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR432101A (fr) 1910-10-26 1911-11-29 I S Petzholdt Maschinen Fabrik Procédé et machine destinés au traitement du cacao fluide
JPS529615B1 (enExample) 1970-03-31 1977-03-17
JPS5747272B2 (enExample) 1974-12-13 1982-10-08
DE2854946A1 (de) 1978-12-20 1980-07-10 Agfa Gevaert Ag Fotografisches farbdiffusionsuebertragungsverfahren
US6638413B1 (en) 1989-10-10 2003-10-28 Lectro Press, Inc. Methods and apparatus for electrolysis of water
CA2104355C (en) 1993-08-18 1997-06-17 Ion I. Inculet Method and apparatus for ozone generation and treatment of water
DE19522619C2 (de) 1995-06-22 1998-11-12 Fischer & Krecke Gmbh & Co Verfahren zur Herstellung von Bodenbeuteln mit Innenriegel
US5876663A (en) 1995-11-14 1999-03-02 The University Of Tennessee Research Corporation Sterilization of liquids using plasma glow discharge
ZA9610018B (en) 1995-11-28 1997-05-28 Austech Pty Ltd Liquid sterilisation apparatus
AUPO502297A0 (en) 1997-02-10 1997-03-06 Austech Pty Ltd Liquid purification apparatus
US5965994A (en) 1997-06-20 1999-10-12 Seo; Dong Il Automatic vertical moving systems and control methods therefor
US6558638B2 (en) 1998-03-14 2003-05-06 Splits Technologies Limited Treatment of liquids
US7527787B2 (en) * 2005-10-19 2009-05-05 Ibc Pharmaceuticals, Inc. Multivalent immunoglobulin-based bioactive assemblies
CA2272596A1 (en) 1999-05-21 2000-11-21 Lawrence A. Lambert Waste water treatment method and apparatus
US6214299B1 (en) 1999-06-01 2001-04-10 Robert J. Holladay Apparatus and method for producing antimicrobial silver solution
US7135195B2 (en) 1999-06-01 2006-11-14 American Silver, Llc Treatment of humans with colloidal silver composition
WO2002096262A2 (en) 2001-05-25 2002-12-05 Northwestern University Non-alloying core shell nanoparticles
US6962679B2 (en) 2001-07-11 2005-11-08 Battelle Memorial Institute Processes and apparatuses for treating halogen-containing gases
US7135054B2 (en) 2001-09-26 2006-11-14 Northwestern University Nanoprisms and method of making them
TWI255695B (en) 2001-10-12 2006-06-01 Phild Co Ltd Method and device for producing ultrafine dispersion of noble metal
TW561085B (en) 2001-10-29 2003-11-11 Phild Co Ltd Method and device for producing metal powder
US7972390B2 (en) 2002-03-21 2011-07-05 Gr Intellectual Reserve, Llc Methods for controlling crystal growth, crystallization, structures and phases in materials and systems
GB0208263D0 (en) 2002-04-10 2002-05-22 Dow Corning Protective coating composition
US7118852B2 (en) 2002-04-11 2006-10-10 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
US6749759B2 (en) 2002-07-12 2004-06-15 Wisconsin Alumni Research Foundation Method for disinfecting a dense fluid medium in a dense medium plasma reactor
US20040022702A1 (en) 2002-07-30 2004-02-05 Christensen Herbert E. Apparatus and method for automatically feeding the silver electrode into the solutiion
JP2004124155A (ja) 2002-10-01 2004-04-22 Sumitomo Electric Ind Ltd 微小金属粉末の製造方法および微小金属粉末の製造装置
US6802981B2 (en) 2002-11-05 2004-10-12 Aquapure Technologies Ltd. Method for purification and disinfection of water
CA2518313A1 (en) * 2003-02-20 2004-09-02 Shetech Co., Ltd. Medicament comprising noble metal fineparticles
US7033415B2 (en) 2003-04-02 2006-04-25 Northwestern University Methods of controlling nanoparticle growth
US20060249705A1 (en) 2003-04-08 2006-11-09 Xingwu Wang Novel composition
KR20060052913A (ko) * 2003-07-28 2006-05-19 더 리전트 오브 더 유니버시티 오브 캘리포니아 랭뮤어-블로젯 나노구조체 단층
JP2007504944A (ja) 2003-09-10 2007-03-08 パランスキ ナフム ナノ粒子及びマイクロ粒子の製造方法
US7276283B2 (en) 2004-03-24 2007-10-02 Wisconsin Alumni Research Foundation Plasma-enhanced functionalization of carbon-containing substrates
US7486705B2 (en) 2004-03-31 2009-02-03 Imra America, Inc. Femtosecond laser processing system with process parameters, controls and feedback
US20060068026A1 (en) * 2004-08-11 2006-03-30 Hu Michael Z Thermal electrochemical synthesis method for production of stable colloids of "naked" metal nanocrystals
US8512436B2 (en) 2004-09-15 2013-08-20 Kyoto University Metal fine particles and manufacturing method therefor
WO2006137851A2 (en) 2004-09-16 2006-12-28 Virginia Tech Intellectual Properties, Inc. Preparation of stable high concentration colloidal metal particulate systems
KR101327660B1 (ko) * 2004-10-05 2013-11-12 아이노벡스 가부시키가이샤 정신 증상의 치료 또는 예방용 조성물 및 방법
US8129199B2 (en) * 2004-12-13 2012-03-06 University of South Caroliina Surface enhanced Raman spectroscopy using shaped gold nanoparticles
BRPI0519604A2 (pt) 2005-01-05 2009-02-25 Robert Holladay composiÇÕes À base de prata/Água, gÉis de prata e prata; e processos para a produÇço e para a utilizaÇço das mesmas
US7588624B2 (en) * 2005-03-10 2009-09-15 Northwestern University Method of producing gold nanoprisms
CN100467118C (zh) 2005-08-08 2009-03-11 鸿富锦精密工业（深圳）有限公司 纳米粒子制备装置
KR100726713B1 (ko) 2005-08-26 2007-06-12 한국전기연구원 액중 전기폭발에 의한 나노분말 제조 방법 및 장치
WO2007044609A1 (en) 2005-10-06 2007-04-19 Pionetics Corporation Electrochemical ion exchange treatment of fluids
US7758846B2 (en) 2005-12-16 2010-07-20 Battelle Memorial Institute Methods of producing hydrogen via the water-gas shift reaction over a Pd-Zn catalyst
US20070267289A1 (en) 2006-04-06 2007-11-22 Harry Jabs Hydrogen production using plasma- based reformation
US8088193B2 (en) 2006-12-16 2012-01-03 Taofang Zeng Method for making nanoparticles
US7862782B2 (en) 2007-01-12 2011-01-04 Wisconsin Alumni Research Foundation Apparatus and methods for producing nanoparticles in a dense fluid medium
SI2178796T1 (sl) * 2007-07-11 2021-04-30 Clene Nanomedicine, Inc. Kontinuiran postopek za obdelavo tekočin in proizvodnjo določenih sestavin
JP2009032756A (ja) * 2007-07-25 2009-02-12 Sony Corp 半導体製造装置
WO2009126341A2 (en) 2008-01-14 2009-10-15 Taofang Zeng Method for making nanoparticles or fine particles
EP2123262A1 (en) * 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
DK2387478T3 (en) * 2009-01-15 2018-10-29 Clene Nanomedicine Inc CONTINUOUS PROCESS AND APPARATUS FOR THE CREATION OF GOLD-BASED NANOPARTICLES
US8246714B2 (en) 2009-01-30 2012-08-21 Imra America, Inc. Production of metal and metal-alloy nanoparticles with high repetition rate ultrafast pulsed laser ablation in liquids
EP2451284B8 (en) * 2009-07-08 2017-05-24 Clene Nanomedicine, Inc. Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US8858676B2 (en) 2010-02-10 2014-10-14 Imra America, Inc. Nanoparticle production in liquid with multiple-pulse ultrafast laser ablation
US8802234B2 (en) 2011-01-03 2014-08-12 Imra America, Inc. Composite nanoparticles and methods for making the same

Also Published As

Publication number Publication date
JP6383763B2 (ja) 2018-08-29
JP2017075390A (ja) 2017-04-20
KR20190133298A (ko) 2019-12-02
SG10202108051XA (en) 2021-09-29
KR102051248B1 (ko) 2019-12-02
RU2012104247A (ru) 2013-08-20
AU2010271298A2 (en) 2012-04-12
KR101931381B1 (ko) 2018-12-20
IL217408A0 (en) 2012-02-29
US20210361699A1 (en) 2021-11-25
US20210236542A1 (en) 2021-08-05
EP2451284A1 (en) 2012-05-16
JP2020128596A (ja) 2020-08-27
US9603870B2 (en) 2017-03-28
US20130259903A1 (en) 2013-10-03
MX2023013237A (es) 2024-11-08
ES2623504T3 (es) 2017-07-11
MX2012000489A (es) 2012-07-30
US20170348350A1 (en) 2017-12-07
JP6059015B2 (ja) 2017-01-11
AU2010271298A1 (en) 2012-03-01
EP2451284A4 (en) 2014-01-22
RU2568850C2 (ru) 2015-11-20
AU2010271298B2 (en) 2015-12-17
EP2451284B1 (en) 2017-03-29
SG10201908339RA (en) 2019-10-30
KR20180135119A (ko) 2018-12-19
PH12017501884A1 (en) 2020-11-23
CN102548417A (zh) 2012-07-04
US20200188429A1 (en) 2020-06-18
IL217408A (en) 2017-12-31
MX350309B (es) 2017-09-01
CA2767428A1 (en) 2011-01-13
BR112012000311B1 (pt) 2021-12-21
SG177565A1 (en) 2012-02-28
WO2011006007A1 (en) 2011-01-13
DK2451284T3 (en) 2017-05-01
EP2451284B8 (en) 2017-05-24
JP6703052B2 (ja) 2020-06-03
CA2767428C (en) 2018-03-13
JP7014851B2 (ja) 2022-02-01
KR102131575B1 (ko) 2020-07-08
JP2019014969A (ja) 2019-01-31
BR112012000311A2 (pt) 2017-06-13
CN102548417B (zh) 2015-09-09
US10449217B2 (en) 2019-10-22
KR20120052967A (ko) 2012-05-24
BR112012000311A8 (pt) 2017-12-05
US10980832B2 (en) 2021-04-20
JP2012532992A (ja) 2012-12-20

Similar Documents

Publication Publication Date Title
IL217408A0 (en) Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
GB2509641B (en) Patient interface and aspects thereof
GB2494493B (en) Patient interface and aspects thereof
PL3251619T3 (pl) Dostosowane szablony chirurgiczne i sposób ich wytwarzania
GB0922085D0 (en) Cancer diagnosis and treatment
EP2508156A4 (en) METHOD AND DEVICE FOR MANUFACTURING ABSORPTION BODIES
EP2461781A4 (en) CARE AND TRANSPORT SET OF SICK
EP2491908A4 (en) METHOD AND DEVICE FOR PRODUCING A SUCTIONABLE ELEMENT
DK3275539T3 (da) Hydrogenbehandlingskatalysatorer og fremstilling deraf
IL216955A0 (en) Medical devices and methods
IL218964A0 (en) Phototriggered nanoparticles for cell and tissue targeting
EP2383818A4 (en) ELECTROCHEMICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME
IL219055A0 (en) Medical devices and pumps therefor
IL214372A0 (en) Means and methods for manufacturing highly pure neurotoxin
IL214133A0 (en) Skin treatment
GB0918392D0 (en) Diagnostic and therapeutic methods
GB0906828D0 (en) Reference electrode and combined electrode
EP2505170A4 (en) DEVICE AND METHOD FOR MANUFACTURING ABSORPTION BODY
EP2405036A4 (en) METHOD OF MANUFACTURING MOLD AND ELECTRODE STRUCTURE FOR USE THEREIN
GB0901837D0 (en) Cancer diagnosis and treatment
ZA201203286B (en) Therapeutic and diagnostic applications against trypanosomosis
EP2444107A4 (en) CONTAMINANTS TREATMENT AGENTS AND METHOD OF MANUFACTURING AND USE THEREOF
GB2472681B (en) Gas treatment cell and apparatus incorporating same
GB201017857D0 (en) Methods for diagnosis and methods of treatment
GB0907098D0 (en) Cancer treatment and diagnosis